The Clinical Significance of N-terminal Pro-brain Natriuretic Peptide in Detecting the Residual Cardiovascular Risk in Hypertension and Other Clinical Conditions and in Predicting Future Cardiovascular Events

被引：4

作者：

Chrysant, Steven G. ^{[1
]}

机构：

[1] Univ Oklahoma, Coll Med, Oklahoma City, OK 73190 USA

来源：

JOURNAL OF CLINICAL HYPERTENSION | 2016年 / 18卷 / 08期

关键词：

HEART-FAILURE; COST-BENEFIT; BIOMARKERS; DISEASE;

D O I：

10.1111/jch.12785

中图分类号：

R6 [外科学];

学科分类号：

100210 [外科学];

摘要：

引用

页码：718 / 720

页数：3

共 15 条

[1]

Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study [J].

Blacher, J. ;

Evans, A. ;

Arveiler, D. ;

Amouyel, P. ;

Ferrieres, J. ;

Bingham, A. ;

Yarnell, J. ;

Haas, B. ;

Montaye, M. ;

Ruidavets, J-B ;

Ducimetiere, P. .

JOURNAL OF HUMAN HYPERTENSION, 2010, 24 (01) :19-26

[2]

B-Type Natriuretic Peptides and Cardiovascular Risk Systematic Review and Meta-Analysis of 40 Prospective Studies [J].

Di Angelantonio, Emanuele ;

Chowdhury, Rajiv ;

Sarwar, Nadeem ;

Ray, Kausik K. ;

Gobin, Reeta ;

Saleheen, Danish ;

Thompson, Alexander ;

Gudnason, Vilmundur ;

Sattar, Naveed ;

Danesh, John .

CIRCULATION, 2009, 120 (22) :2177-U39

[3]

Ruling out cardiac failure: Cost-benefit analysis of a sequential testing strategy with NT-proBNP before echocardiography [J].

Ferrandis, Maria-Jose ;

Ryden, Ingvar ;

Lindahl, Tomas L. ;

Larsson, Anders .

UPSALA JOURNAL OF MEDICAL SCIENCES, 2013, 118 (02) :75-79

[4]

Ruling out heart failure in primary-care: The cost-benefit of pre-screening using NT-proBNP and QRS width [J].

Goode, Kevin M. ;

Clark, Andrew L. ;

Cleland, John G. F. .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 130 (03) :426-437

[5]

PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease) [J].

Huelsmann, Martin ;

Neuhold, Stephanie ;

Resl, Michael ;

Strunk, Guido ;

Brath, Helmut ;

Francesconi, Claudia ;

Adlbrecht, Christopher ;

Prager, Rudolf ;

Luger, Anton ;

Pacher, Richard ;

Clodi, Martin .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (15) :1365-1372

[6]

Natriuretic Peptide Testing in Heart Failure [J].

Kim, Han-Na ;

Januzzi, James L., Jr. .

CIRCULATION, 2011, 123 (18) :2015-2019

[7]

N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population [J].

Linssen, Gerard C. M. ;

Bakker, Stephan J. L. ;

Voors, Adriaan A. ;

Gansevoort, Ron T. ;

Hillege, Hans L. ;

de Jong, Paul E. ;

van Veldhuisen, Dirk J. ;

Gans, Rijk O. B. ;

de Zeeuw, Dick .

EUROPEAN HEART JOURNAL, 2010, 31 (01) :120-127

[8]

Improving the Primary Prevention of Cardiovascular Events by Using Biomarkers to Identify Individuals With Silent Heart Disease [J].

Nadir, M. Adnan ;

Rekhraj, Sushma ;

Wei, Li ;

Lim, Tiong K. ;

Davidson, John ;

MacDonald, Thomas M. ;

Lang, Chim C. ;

Dow, Ellie ;

Struthers, Allan D. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (11) :960-968

[9]

N-Terminal Pro-Brain Natriuretic Peptide A Powerful Predictor of Mortality in Hypertension [J].

Paget, Vinciane ;

Legedz, Liliana ;

Gaudebout, Nathalie ;

Girerd, Nicolas ;

Bricca, Giampiero ;

Milon, Hugues ;

Vincent, Madeleine ;

Lantelme, Pierre .

HYPERTENSION, 2011, 57 (04) :702-709

[10]

N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study [J].

Price, Anna H. ;

Welsh, Paul ;

Weir, Christopher J. ;

Feinkohl, Insa ;

Robertson, Christine M. ;

Morling, Joanne R. ;

McLachlan, Stela ;

Strachan, Mark W. J. ;

Sattar, Naveed ;

Price, Jackie F. .

DIABETOLOGIA, 2014, 57 (12) :2505-2512

← 1 2 →